FierceMedTech Names Analytics 4 Life as One of its Fierce 15 MedTech Companies of 2017

On Tuesday, Analytics 4 Life — a digital health company applying the power of artificial intelligence to develop solutions that improve existing care pathways — today announced that it has been named by FierceMedTech as one of 2017’s Fierce 15 medtech companies, designating it as one of the most promising private medtech companies in the industry.

Analytics 4 Life’s innovative technology combines artificial intelligence, cloud computing, and digital technologies to develop a proprietary approach to cardiac imaging, Phase Space Tomograph.

The first application of this technology is CorVista, a physician-directed diagnostic test that aims to assist in identifying the presence of coronary artery disease (CAD) without the use of radiation, cardiac stress, contrast agents, or patient fasting.

CorVista is currently undergoing a clinical study at 13 sites in the U.S. to support algorithm development and regulatory filings.

“Analytics 4 Life is honored to be recognized as one of the most innovative medtech companies selected for this year’s FierceMedTech Fierce 15,” said Don Crawford, Analytics 4 Life chief executive officer. “We’re proud to pioneer Phase Space Tomography, and are looking forward to working closely with the FDA to bring this game-changing technology to the millions of people affected by CAD.”

This post was written by:

- who has written 626 posts on mHealthWatch.

Contact the author